These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24158497)

  • 1. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.
    Li L; Ying J; Tong X; Zhong L; Su X; Xiang T; Shu X; Rong R; Xiong L; Li H; Chan AT; Ambinder RF; Guo Y; Tao Q
    Cell Mol Life Sci; 2014 Jun; 71(11):2179-92. PubMed ID: 24158497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
    Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
    Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
    Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
    World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
    Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
    Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
    Lee SE; Lim SD; Kang SY; Suh SB; Suh YL
    Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
    BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
    Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):243-54. PubMed ID: 25209439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
    Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
    Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas.
    Li L; Ying J; Li H; Zhang Y; Shu X; Fan Y; Tan J; Cao Y; Tsao SW; Srivastava G; Chan AT; Tao Q
    Oncogene; 2012 Aug; 31(34):3901-12. PubMed ID: 22139084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
    O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
    Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt-5a-Receptor Tyrosine Kinase-Like Orphan Receptor 2 Signaling Provokes Metastatic Colonization and Angiogenesis in Renal Cell Carcinoma, and Prunetin Supresses the Axis Activation.
    Chuang WY; Lee CW; Fan WL; Liu TT; Lin ZH; Wang KC; Huang PJ; Yeh YM; Lin TC
    Am J Pathol; 2024 Oct; 194(10):1967-1985. PubMed ID: 39069169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
    Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
    Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
    Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
    Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of Wnt signaling pathway in keloid pathogenesis.
    Igota S; Tosa M; Murakami M; Egawa S; Shimizu H; Hyakusoku H; Ghazizadeh M
    Int J Med Sci; 2013; 10(4):344-54. PubMed ID: 23471552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
    Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
    Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
    Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition.
    Ren D; Minami Y; Nishita M
    Genes Cells; 2011 Mar; 16(3):304-15. PubMed ID: 21342370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
    Endo M; Nishita M; Fujii M; Minami Y
    Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling.
    Mikels A; Minami Y; Nusse R
    J Biol Chem; 2009 Oct; 284(44):30167-76. PubMed ID: 19720827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression.
    Yamagata K; Li X; Ikegaki S; Oneyama C; Okada M; Nishita M; Minami Y
    J Biol Chem; 2012 Jan; 287(2):1588-99. PubMed ID: 22128168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.